JP2016501266A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501266A5
JP2016501266A5 JP2015547006A JP2015547006A JP2016501266A5 JP 2016501266 A5 JP2016501266 A5 JP 2016501266A5 JP 2015547006 A JP2015547006 A JP 2015547006A JP 2015547006 A JP2015547006 A JP 2015547006A JP 2016501266 A5 JP2016501266 A5 JP 2016501266A5
Authority
JP
Japan
Prior art keywords
protein
modified
protein according
seq
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015547006A
Other languages
English (en)
Japanese (ja)
Other versions
JP6518193B2 (ja
JP2016501266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/076289 external-priority patent/WO2014090905A1/en
Publication of JP2016501266A publication Critical patent/JP2016501266A/ja
Publication of JP2016501266A5 publication Critical patent/JP2016501266A5/ja
Application granted granted Critical
Publication of JP6518193B2 publication Critical patent/JP6518193B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015547006A 2012-12-11 2013-12-11 改善された特性を有する改変コイルドコイル型タンパク質 Active JP6518193B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12306560.9 2012-12-11
EP12306560 2012-12-11
US201361802836P 2013-03-18 2013-03-18
US61/802,836 2013-03-18
PCT/EP2013/076289 WO2014090905A1 (en) 2012-12-11 2013-12-11 Modified coiled coil type proteins having improved properties

Publications (3)

Publication Number Publication Date
JP2016501266A JP2016501266A (ja) 2016-01-18
JP2016501266A5 true JP2016501266A5 (enExample) 2017-01-26
JP6518193B2 JP6518193B2 (ja) 2019-05-22

Family

ID=47458800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015547006A Active JP6518193B2 (ja) 2012-12-11 2013-12-11 改善された特性を有する改変コイルドコイル型タンパク質

Country Status (12)

Country Link
US (1) US9388225B2 (enExample)
EP (1) EP2931896B1 (enExample)
JP (1) JP6518193B2 (enExample)
KR (1) KR102237130B1 (enExample)
CN (1) CN104981541B (enExample)
AU (1) AU2013357367B2 (enExample)
BR (1) BR112015013387B8 (enExample)
CA (1) CA2893120C (enExample)
MX (1) MX363443B (enExample)
PL (1) PL2931896T3 (enExample)
RU (1) RU2677799C2 (enExample)
WO (1) WO2014090905A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2976357B1 (en) * 2013-03-18 2018-10-17 Osivax SAS Influenza nucleoprotein vaccines
US10111948B2 (en) 2014-04-25 2018-10-30 Tria Bioscience Corp. Synthetic hapten carrier compositions and methods
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
RU2732013C1 (ru) * 2019-12-11 2020-09-10 Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) Способ сенсибилизации планшета для иммуноферментного анализа нерастворимыми белковыми антигенами
KR102613348B1 (ko) * 2020-01-07 2023-12-13 에이치케이이노엔 주식회사 알부민 및 코일드코일 형성 도메인이 연결된 융합단백질, 및 이를 이용한 이중 표적 결합체
CN115322247B (zh) * 2021-05-11 2025-07-15 中国人民解放军军事科学院军事医学研究院 一种新型冠状病毒受体结合区电荷突变体抗原及应用
EP4392066A1 (en) 2021-08-24 2024-07-03 Osivax Immunogenic compositions and their use
KR20240125000A (ko) 2021-12-22 2024-08-19 오시벡스 백신 조성물 및 이의 용도
CA3253732A1 (en) 2022-03-22 2023-09-28 Osivax mRNA VACCINE COMPOSITIONS AND THEIR USE
NL2031833B1 (en) 2022-05-11 2023-11-17 Univ Leiden Immunotherapeutic compositions and adjuvants
CN115779079A (zh) * 2022-10-01 2023-03-14 中国人民解放军军事科学院军事医学研究院 一种可增强与佐剂协同免疫效力的电荷调控型抗原蛋白

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9222598A (en) * 1997-09-04 1999-03-22 Stanford University Reversible immobilization of arginine-tagged moieties on a silicate surface
CA2405438C (en) * 2000-04-07 2011-07-12 University Of Leeds Innovations Limited Hepatitis b core antigen fusion proteins
US7270921B2 (en) * 2002-02-08 2007-09-18 Kabushiki Kaisha Toshiba Pattern writing and forming method
CA2514841A1 (en) * 2003-02-02 2004-08-19 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
PT1648500E (pt) * 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
WO2005077976A2 (en) 2004-02-13 2005-08-25 Avidis Sa Coiled-coil domains from c4b-binding protein
US7960312B2 (en) * 2005-11-10 2011-06-14 National University Of Corporation Hiroshima University Method and agent for immobilizing protein via protein bound to silicon oxide-containing substance
EP1795540A1 (en) 2005-11-30 2007-06-13 Imaxio Multimeric complexes of antigens and an adjuvant
DK1996238T3 (da) 2006-02-28 2016-08-01 Vaxart Inc Kimæriske adenovirale vektorer og DsRNA som TLR3-agonist
GB0706912D0 (en) 2007-04-10 2007-05-16 Isis Innovation Novel viral vaccines
EP2060586A1 (en) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
GB0918154D0 (en) 2009-10-16 2009-12-02 Isis Innovation Mycobacterial vaccines
EP2976357B1 (en) * 2013-03-18 2018-10-17 Osivax SAS Influenza nucleoprotein vaccines

Similar Documents

Publication Publication Date Title
JP2016501266A5 (enExample)
RU2015126105A (ru) Модифицированные суперспиральные белки с улучшенными свойствами
IL288541B (en) Vaccine against rsv
CY1122691T1 (el) Πρωτεϊνες δεσμευσης αλβουμινης ορου
JP2017514522A5 (enExample)
JP2013172734A5 (enExample)
HRP20192314T1 (hr) Pripravci faktora viii i postupci pripreme i njihove uporabe
PH12018501912A1 (en) Vaccine against rsv
JP2015212284A5 (enExample)
RU2016146198A (ru) Терапевтические dll4-связывающие белки
JP2014530010A5 (enExample)
JP2012115277A5 (enExample)
HRP20200036T1 (hr) Postupci liječenja tauopatije
JP2018532725A5 (enExample)
JP2018512856A5 (enExample)
JP2015525217A5 (enExample)
JP2013504301A5 (enExample)
JP2015501656A5 (enExample)
JP2016508503A5 (enExample)
JP2015509707A5 (enExample)
JP2017507181A5 (enExample)
HRP20191166T1 (hr) Stabilizirani proteini, namijenjeni imuniziranju protiv bakterije staphylococcus aureus
EA202090738A1 (ru) Способ безопасного индуцирования иммунитета против rsv
JP2014507146A5 (enExample)
JP2013531993A5 (enExample)